MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testing
Download PDF Read more
Category: M&A, Partnerships
GrandOmics Biosciences Expands Investment in PacBio’s Sequel Systems for Precision Medicine Initiative
MENLO PARK, Calif. and BEIJING, Jan. 04, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that GrandOmics Biosciences Co., Ltd of Beijing, through its subsidiary NextOmics in Wuhan, has agreed to purchase five additional Sequel™ instruments to support China’s precision medicine initiative, with a specific focus on ultimately providing the genetic... Read more
BioLife Solutions Restructures biologistex™ Joint Venture
Consolidation of Cold Chain Technologies Enables External Investment in evo™ Smart Shipper and biologistex SaaS Opportunity BOTHELL, Wash., Jan. 3, 2017 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers (“BioLife”) today announced the restructuring of... Read more
Agilent Technologies to Acquire Multiplicom N.V., a Leading European Diagnostics Company with State-of-the-Art Genetic Testing Technology and Products
Agilent fortifies its target-enrichment portfolio through its planned acquisition of Multiplicom N.V. SANTA CLARA, Calif. & NIEL, Belgium–(BUSINESS WIRE)–Dec. 20, 2016– Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a leading European diagnostics company with state-of-the-art genetic testing technology and products.... Read more
Fujifilm to Acquire Wako Pure Chemical Industries from Takeda Pharmaceutical by Tender Offer
December 15, 2016 FUJIFILM Corporation (President & COO: Kenji Sukeno) (“Fujifilm”) is pleased to announce that it approved the acquisition of a leading reagent manufacturer Wako Pure Chemical Industries, Ltd. (President: Shinzo Kobatake) (“Wako”) at today’s Board of Directors Meeting. Fujifilm signed an agreement with Takeda Pharmaceutical Company Limited (President & CEO: Christophe Weber) (“Takeda”)... Read more
Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus
Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus Kusatsu/Shiga, Japan — December 15, 2016 — Takara Bio Inc. (Takara) announced today that it has entered into an exclusive license agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) for co-development and commercialization in Japan of the oncolytic virus... Read more
Takara Bio USA Holdings, Inc. and Rubicon Genomics Announce Merger Agreement
Takara Bio USA Holdings, Inc. and Rubicon Genomics Announce Merger Agreement Mountain View, CA and Ann Arbor, MI —December 15, 2016—Takara Bio USA Holdings, Inc. (“TBUSH”) and Rubicon Genomics, Inc. (“Rubicon”), today announced the signing of a merger agreement pursuant to which TBUSH will acquire Rubicon, a privately-owned company headquartered in Ann Arbor, Michigan. Rubicon... Read more
Malvern Instruments and PANalytical to merge
2 December 2016 – Spectris plc (SXS: LSE), the productivity-enhancing instrumentation and controls company, announces that effective 1 January 2017, Malvern Instruments (‘Malvern’) and PANalytical will be merging their activities. Both Malvern and PANalytical are operating companies within the Materials Analysis segment of Spectris. The companies are both world leading suppliers of analytical instrumentation, PANalytical... Read more